Catheter Robotics has completed the acquisition of a new product line to be named VIVO (View Into Ventricular Onset). VIVO is a computerised three-dimensional cardiac mapping system designed to show electrical activation of the ventricles of the heart.
Catheter Robotics has also chosen to change its name to Catheter Precision. Both the company’s Amigo and VIVO products are oriented towards providing precision for catheter procedures in cardiac electrophysiology including both atrial fibrillation and ventricular arrhythmias, according to a press release. Vivo is intended to allow the physician to accurately pinpoint the origin of a ventricular arrhythmia. The company intends to seek US Food and Drug Administration approval later this year.
Missiaen Huck, director of Marketing for Catheter robotics comments, “For the last ten to fifteen years new catheter technologies have been focused on treating atrial fibrillation. Our new VIVO technology is for catheter treatment of ventricular arrhythmias. Our technology should allow the catheter procedures to be accepted and used on a general basis, even in the community hospitals.”